Erschienen in:
01.10.2019 | Gynecologic Oncology
Transarterial embolisation for the treatment of acute gynecological cancer bleeding
verfasst von:
Philipp Meyer-Wilmes, Maciej Powerski, Frank Fischbach, Jazan Omari, Robert Damm, Maciej Pech
Erschienen in:
Archives of Gynecology and Obstetrics
|
Ausgabe 5/2019
Einloggen, um Zugang zu erhalten
Abstract
Purpose
Acute bleeding in patients with gynecological cancer may result in serious life-threatening complications. In these situations, immediate diagnostic and appropriate treatment is a challenge for attending physicians. Accordingly, transarterial embolisation (TAE) has been described as an increasing and effective treatment alternative to surgery and radiotherapy.
Methods
In the present retrospective study, 25 patients were included who underwent a TAE in the period from January 2006 to June 2013 due to acute gynecological cancer bleeding. The objective of this study was to assess the efficiency and outcome of TAE.
Results
The primary technical success rate was 92.0% (n = 23). 21 patients were analyzed in the 30-day follow-up. The clinical success rate was achieved in 90.5% (n = 19). A clinical failure due to rebleeding was observed in 9.5% (n = 2). No associations were revealed between rebleeding and technical/clinical factors. Within 30 days after the last TAE, the complication and mortality rates were 0.0% and 5.0% (n = 1), respectively.
Conclusion
TAE was found as an effective and safe treatment in the clinical setting of acute gynecological cancer bleeding. An important component of efficient management is an early and interdisciplinary care. Optimal treatment can be achieved by close cooperation between gynecologists, radiotherapists and interventional radiologists.